Bio-Rad Launches SARS-CoV-2 S Gene Alpha, Beta, Gamma, and Epsilon Variant Controls

The Exact Diagnostics SARS-CoV-2 S Gene Alpha Variant Control consists of a synthetic RNA transcript of the Alpha variant SARS-CoV-2 S gene (Lineage B.1.1.7) in a matrix simulating transport media. This product also contains human genomic DNA (human gDNA; which includes the human RNase P) for internal control needs, allowing laboratories to monitor the entire process of a molecular assay including extraction, amplification, and detection. The extraction of this product is optional.

The Exact Diagnostics SARS-CoV-2 S Gene Beta Variant Control consists of a synthetic RNA transcript of the Beta variant SARS-CoV-2 S gene (Lineage B.1.351) in a matrix simulating transport media. This product also contains human genomic DNA (human gDNA; which includes the human RNase P) for internal control needs, allowing laboratories to monitor the entire process of a molecular assay including extraction, amplification, and detection. The extraction of this product is optional.

The Exact Diagnostics SARS-CoV-2 S Gene Epsilon Variant Control consists of a synthetic RNA transcript of the Epsilon variant SARS-CoV-2 S gene (Lineage B.1.429) in a matrix simulating transport media. This product also contains human genomic DNA (human gDNA; which includes the human RNase P) for internal control needs, allowing laboratories to monitor the entire process of a molecular assay including extraction, amplification, and detection. The extraction of this product is optional.

The Exact Diagnostics SARS-CoV-2 S Gene Gamma Variant Control consists of a synthetic RNA transcript of the Gamma variant SARS-CoV-2 S gene (Lineage P.1) in a matrix simulating transport media. This product also contains human genomic DNA (human gDNA; which includes the human RNase P) for internal control needs, allowing laboratories to monitor the entire process of a molecular assay including extraction, amplification, and detection. The extraction of this product is optional.